- Acorda Therapeutics
- according to Bloomberg's Natasha Rausch.
- Read Bloomberg's full story here.
ADVERTISEMENT
Acorda Therapeutics crashes 40% after patients die in drug trial (ACOR)
The drug company was in the final stages of a drug trial when several people in the trial died.
ADVERTISEMENT
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Top 10 African countries with the highest fuel prices in April 2024
The gold trade in Uganda makes a huge comeback
Best live dealer casino: Top USA live casinos online
Best real money online casinos USA: Top 10 casino sites in 2024
OPEC excited about partnership with Namibia
The US loses to Russia and China in popularity across Africa
Top 10 most valuable South African brands in 2024
Africa's giants play tug of war for the top economic spot